Stay updated with breaking news from Biosight Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 27, 2024 ________________________ Dear NeuroSense Therapeutics Ltd....
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncol...
10.08.2023 - Successful End-of-Phase 2 meeting with FDA regarding AL102 for the treatment of desmoid tumors Enrollment in the Phase 3 segment of RINGSIDE trial evaluating AL102 continuing globally as planned Definitive merger agreement with Biosight, expected ...
The combined company will operate under the name Ayala Pharmaceuticals Inc.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.